|

mFOLFOX6 regimen Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: mFOLFOX6

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Sixth Affiliated Hospital, Sun Yat-sen University2
  • Revolution Medicines, Inc.1

Indications

  • Cancer3
  • Rectal Adenocarcinoma2
  • High-Risk Cancer2
  • MSS2
  • PDAC1

Other2 trials

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Phase 3
SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)
Phase 2

Chandler, Arizona1 trial

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Ironwood Cancer and Research Centers

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.